Fig 1: Coronal sections of the spinal cord obtained from the dogs treated with bone marrow–derived mononuclear cells (BM-MNCs) (a) 1 week (dog #1), (b) 2 weeks (dog #3), and (c) 4 weeks (dog #5) after spinal cord injury (SCI) induction and BM-MNC transplantation and from the control group (d) 1 week (dog #2), (e) 2 weeks (dog #4), and (f) 4 weeks (dog #6) after SCI induction and saline treatment (bar: 200 μm). The white dotted line indicates the border between the intact and injured areas of the spinal cord (∗: region of SCI). Arrowheads indicate the regions of GAP-43 expression. Merged images depict the areas with different types of fluorescence shown in specific colors (blue: 4′,6-diamidino-2-phenylindole; green: GAP-43 protein; mixed colors: autofluorescent tissues). In the BM-MSC–treated group, GAP-43 expression was sporadically observed in the spinal cord parenchyma in the vicinity of SCI 1 week after SCI induction (a). GAP-43 expression was concentrated at the border between the injured and intact areas of the spinal cord 2 weeks after SCI induction (b) and persisted in the limbus of the region of SCI 4 weeks after SCI induction (c). In the control group, we found no GAP-43 expression 1 week after SCI induction (d) and unremarkable GAP-43 expression 2 weeks after SCI induction (e). However, 4 weeks after SCI induction, we observed GAP-43 expression in the spinal cord parenchyma in the vicinity of SCI (f).
Fig 2: Growth-associated protein 43 (GAP-43) expression following bone marrow–derived mononuclear cell (BM-MNC) transplantation in the canine model of spinal cord injury detected by fluorescence: (a) 4′,6-diamidino-2-phenylindole (DAPI). (b) Autofluorescence. (c) GAP-43 protein. (d) A merged image (×40). The BM-MNC–treated group at 1, 2, and 4 weeks (a). The control group at 1, 2, and 4 weeks (b). In the BM-MNC–treated group, GAP-43 expression was clearly observed 1, 2, and 4 weeks after SCI induction. In the control group, we found no GAP-43 expression 1 week after SCI induction; however, we detected moderate GAP-43 expression after 2 weeks and clear GAP-43 expression after 4 weeks.
Supplier Page from Novus Biologicals, a Bio-Techne Brand for GAP-43 Antibody [DyLight 488]
Available conjugates: Available conjugates: DyLight 488Sizes Available: 0.1 ml